{
    "testId": 378103357,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 32,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 17,
    "correctToIncorrect": 1,
    "incorrectToCorrect": 0,
    "incorrectToIncorrect": 0,
    "timeInSeconds": 126,
    "averageTimeSpentInSeconds": 174,
    "otherAverageTimeSpentInSeconds": 70,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 20,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 23565,
            "questionIndex": 107800,
            "questionText": "<p>Dynamic stimulation tests are typically used to diagnose adrenal insufficiency.&nbsp; The insulin tolerance test (ITT) is considered the gold standard test for evaluating the hypothalamic-pituitary-adrenal (HPA) axis.&nbsp; However, the ITT is unpleasant and potentially dangerous due to the risk of hypoglycemia.&nbsp; A good, although more time-consuming, alternative is the glucagon stimulation test (GST).&nbsp; A prospective study was conducted to compare the ITT and the GST in the evaluation of the HPA axis in patients with pituitary disorders.&nbsp; Both tests were performed within 7 days in 81 patients. &nbsp;Serum cortisol levels were measured.&nbsp; Participants were divided into those with adrenal insufficiency and those with normal response based on predefined&nbsp;peak cortisol levels in the ITT.&nbsp; Receiver operating characteristic (ROC) analysis was performed to identify a potential peak cortisol level cut point value for the GST.&nbsp; The ROC curve analysis of peak cortisol values in the GST in patients with pituitary disorders is shown below.</p><p><img  draggable=\"false\" id=\"59397\" src=\"https://www.uworld.com/media/highresdefault/L90025.png\"  ></p><p>The labeled points in the ROC graph represent 5&nbsp;cut point values evaluated in the study.&nbsp; Which of the following peak cortisol level cut points represents the best diagnostic accuracy?</p>",
            "questionHeader": "",
            "explanationText": "<p>A <strong>receiver operating characteristic (ROC) curve</strong> for a given diagnostic test plots sensitivity on the <em>y</em>-axis and (1 &#8722; specificity), or equivalently (100% &#8722; specificity), on the <em>x</em>-axis.</p><ul><li><p><strong>Sensitivity</strong> is the test&#39;s ability to correctly identify patients with disease as positive.&nbsp; It represents the <strong>rate of true positives</strong>, or true-positive rate (TPR).</p></li><li><p>Specificity is the test&#39;s ability to correctly identify patients without disease as negative.&nbsp; It represents the rate of true negatives.&nbsp; Therefore, <strong>(1 &#8722; specificity)</strong> represents the <strong>rate of false positives</strong>, or false-positive rate (FPR).</p></li></ul><p>The <strong>best cutoff</strong> for a diagnostic test (ie, the cutoff with the <strong>best diagnostic accuracy</strong>) is the one that provides the best compromise of correctly identifying patients with disease as positive (ie, <strong>highest TPR</strong>) and correctly identifying those without disease as negative (ie, <strong>lowest FPR</strong>).</p><p>In the ROC graph shown, the sensitivity and specificity for each peak cortisol level cut point are as follows:</p><div id=\"div_T89474\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Cut point value</strong></p></td><td><p align=\"center\"><strong>Sensitivity</strong></p><p align=\"center\"><strong>(TPR)</strong></p></td><td><p align=\"center\"><strong>1 &#8722; specificity</strong></p><p align=\"center\"><strong>(FPR)</strong></p></td></tr><tr><td><p><strong>A</strong></p></td><td><p align=\"center\">77 ng/mL</p></td><td><p align=\"center\">30%</p></td><td><p align=\"center\">0%</p></td></tr><tr><td><p><strong>B</strong></p></td><td><p align=\"center\">124 ng/mL</p></td><td><p align=\"center\">70%</p></td><td><p align=\"center\">20%</p></td></tr><tr><td><p><strong>C</strong></p></td><td><p align=\"center\">167 ng/mL</p></td><td><p align=\"center\">90%</p></td><td><p align=\"center\">20%</p></td></tr><tr><td><p><strong>D</strong></p></td><td><p align=\"center\">234 ng/mL</p></td><td><p align=\"center\">90%</p></td><td><p align=\"center\">40%</p></td></tr><tr><td><p><strong>E</strong></p></td><td><p align=\"center\">292 ng/mL</p></td><td><p align=\"center\">100%</p></td><td><p align=\"center\">90%</p></td></tr></tbody></table></div><p>Although cut point E (292 ng/mL) has the highest TPR, it also has the highest FPR, which indicates poor diagnostic accuracy in patients without disease.&nbsp; <strong>Cut points C</strong> (ie, 167 ng/mL) and D (ie, 234 ng/mL) have the next <strong>highest TPR</strong> (ie, both 90%), but the <strong>FPR is lower</strong> for cut point C (ie, 20%) than for cut point D (ie, 40%).&nbsp; Therefore, on the GST, the peak cortisol level cut point with the best diagnostic accuracy is <strong>167 ng/mL</strong>.</p><p><strong>Educational objective:</strong><br>The best cutoff threshold for a quantitative diagnostic test represents the best compromise of highest true-positive rate and lowest false-positive rate.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 20454,
            "topic": "Receiver Operating Characteristic",
            "titleId": 20454,
            "title": "Receiver Operating Characteristic",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "77 ng/mL",
                    "choiceNumber": 1,
                    "correctTaken": 344,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "124 ng/mL",
                    "choiceNumber": 2,
                    "correctTaken": 92,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "167 ng/mL",
                    "choiceNumber": 3,
                    "correctTaken": 4484,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "234 ng/mL",
                    "choiceNumber": 4,
                    "correctTaken": 96,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "292 ng/mL",
                    "choiceNumber": 5,
                    "correctTaken": 649,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 174,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 5665,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1618,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 2151,
            "questionIndex": 2151,
            "questionText": "<p>A study evaluated the relationship between the common cold and the number of cigarettes smoked per day.&nbsp; The research was conducted among fourth-year medical students and sponsored by the public health department of the medical school.&nbsp; Medical students with symptoms of common cold were interviewed about their smoking status, number of packs smoked per day, and duration of smoking.&nbsp; All participants completed the interview and their data analyzed.&nbsp; Based on this information, which of the following is of most concern regarding the study?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Response bias</strong> occurs when participants in cross-sectional studies (eg, surveys, polls, questionnaires, interviews) purposely give desirable responses to questions about topics perceived to be sensitive (eg, health behaviors).&nbsp; Biased <strong>responses</strong> become less useful as they are <strong>inaccurate</strong> and may lead to <strong>incorrect conclusions</strong> (eg, lower than expected prevalence of disease or frequency of risk factors).</p><p>In this example, medical students likely know the risk of smoking and may purposely report smoking a lesser number of cigarettes than they truly smoke, especially to interviewers from the public health department of their institution.&nbsp; This underreporting may significantly affect the results of the study.</p><p><strong>(Choice A)</strong>&nbsp; Admission rate bias occurs when a distortion in risk ratio exists due to hospitals&#39; differing admission rates for certain cases.&nbsp; For instance, patients with cardiac diseases may be admitted to hospitals with more specialized cardiology services.</p><p><strong>(Choice B)</strong>&nbsp; Lead-time bias occurs when a screening test diagnoses a disease earlier than it would have appeared by natural history alone, so that the time from diagnosis until death appears prolonged even though there might actually be no improvement in survival.</p><p><strong>(Choice C)</strong>&nbsp; Nonresponse bias occurs when respondents differ from nonrespondents in such meaningful ways that threaten the generalizability of study results.&nbsp; All participants in this study completed the interview, so there were no nonrespondents.</p><p><strong>(Choice D)</strong>&nbsp; Regression to the mean refers to a set of data where the first assessment of a variable reveals an extreme value but repeat assessment reveals values closer to the center of the distribution of that variable.</p><p><strong>Educational objective:</strong><br>Response bias occurs when participants purposely give desirable responses to questions about topics perceived to be sensitive (eg, health behaviors).&nbsp; This practice results in responses that are inaccurate and may lead to incorrect conclusions (eg, lower than expected prevalence of disease or frequency of risk factors).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24175,
            "topic": "Bias",
            "titleId": 24175,
            "title": "Bias",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Admission rate bias",
                    "choiceNumber": 1,
                    "correctTaken": 1956,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lead-time bias",
                    "choiceNumber": 2,
                    "correctTaken": 345,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nonresponse bias",
                    "choiceNumber": 3,
                    "correctTaken": 1316,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Regression to the mean",
                    "choiceNumber": 4,
                    "correctTaken": 324,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Response bias",
                    "choiceNumber": 5,
                    "correctTaken": 8130,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 80,
            "othersAvgTimeSpent": 39,
            "notes": null,
            "peopleTaken": 12071,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 491,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 7690,
            "questionIndex": 7690,
            "questionText": "<table border=\"0\" cellpadding=\"5\" cellspacing=\"0\" width=\"100%\"><tbody><tr><td id=\"vignettedescriptor\" width=\"100%\">The abstract shown on the left applies to the next <strong>2</strong> items</td></tr></tbody></table><p><strong>Item 1 of 2</strong></p><p>A 67-year-old man recently diagnosed with coronary artery disease comes to the physician for a follow-up appointment.&nbsp; He was hospitalized for congestive heart failure 4 weeks ago and underwent coronary angiography showing significant narrowing of left anterior descending and right coronary arteries with &lt;50% stenosis.&nbsp; The patient&#39;s left ventricular ejection fraction is 30%.&nbsp; Prior to starting medication, he could walk only 3 blocks on a flat surface before experiencing chest discomfort and shortness of breath.&nbsp; However, now he is symptomatic only with strenuous physical activity.&nbsp; During the appointment, the patient asks about the risks and benefits of coronary bypass surgery.&nbsp; Based on the study results, which of the following is the best statement?</p>",
            "questionHeader": "",
            "explanationText": "<p>The study presented in the abstract is a randomized clinical trial comparing the benefit of coronary-artery bypass grafting (CABG) with medical therapy versus medical therapy alone for the management of coronary artery disease and heart failure (defined as &lt;35% left ventricular ejection fraction [EF]).&nbsp; This patient meets the inclusion criteria for the study (EF &lt;35%, coronary artery disease with &lt;50% stenosis [patients with &gt;50% stenosis were excluded from the study], minimal symptoms while receiving medical therapy), so the study findings are likely to apply to him.</p><p>The results of the study are reported in terms of the hazard ratio, which is the ratio of an event rate occurring in the treatment group compared to an event rate occurring in the non-treatment group.&nbsp; A ratio &lt;1 indicates that the treatment group had a lower event rate and a value &gt;1 indicates that the treatment group had a higher event rate.</p><p>In this study, overall mortality was the primary end point.&nbsp; The hazard ratio for all-cause mortality was 0.86 (CI=[0.72-1.04], p=0.12).&nbsp; However, the p-value is &gt;0.05, meaning that there was no significant difference in all-cause mortality between the study groups during the average follow-up period of 56 months.&nbsp; In contrast, CABG with medical therapy was associated with a significantly higher mortality in the first 30 days after randomization than medical therapy alone, with a hazard ratio of 3.12 (CI=[1.33-7.31], p=0.006).&nbsp; This is most likely due to the inherent risks of surgery and related short-term postoperative complications (risks that should be explicitly conveyed to the patient).</p><p><strong>(Choice B)</strong>&nbsp; The hazard ratio for death due to any cause or hospitalization for heart failure was 0.84 (CI=[0.71-0.98], p=0.03).&nbsp; This means that surgery in addition to medical therapy improves heart failure symptoms compared to medical therapy alone as all-cause mortality was not significantly different between the 2 groups (given p = 0.12 as explained above).</p><p><strong>(Choice C)</strong>&nbsp; The hazard ratio for death due to any cause or revascularization was 0.60 (CI=[0.51-0.71], p &lt;0.001).&nbsp; This indicates that the surgery in addition to medical therapy leads to fewer revascularization procedures than medical therapy alone, since all-cause mortality is not significantly different between the 2 groups.</p><p><strong>(Choice D)</strong>&nbsp; The hazard ratio for death or hospitalization due to any cause was 0.81 (CI=[0.71-0.93], p=0.003).&nbsp; This indicates that the surgery added to medical therapy leads to fewer hospitalizations than medical therapy alone because all-cause mortality was not significantly different between the 2 groups.&nbsp; Fewer hospitalizations help to improve patient quality of life.</p><p><strong>(Choice E)</strong>&nbsp; All the secondary outcomes except 30-day mortality were favorable for surgery with medical therapy, indicating that there are other benefits to surgery with medical therapy aside from heart attack prevention.</p><p><strong>Educational objective:</strong><br>Hazard ratios are the ratio of an event rate occurring in the treatment group versus the non-treatment group.&nbsp; Ratios &lt;1 indicate that the treatment group had a lower event rate and ratios &gt;1 indicate that the treatment group had a higher event rate.</p>",
            "abstractId": 3,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 19502,
            "topic": "Study designs",
            "titleId": 19502,
            "title": "Study designs",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 7690,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Surgery carries a higher short-term risk of dying",
                    "choiceNumber": 1,
                    "correctTaken": 65358,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Surgery causes increased risk of heart failure exacerbation",
                    "choiceNumber": 2,
                    "correctTaken": 3217,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Surgery leads to more procedures over the long term",
                    "choiceNumber": 3,
                    "correctTaken": 4188,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Surgery would not affect overall long-term quality of life",
                    "choiceNumber": 4,
                    "correctTaken": 29453,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The benefits of surgery are limited to preventing a heart attack",
                    "choiceNumber": 5,
                    "correctTaken": 8013,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 3,
            "highlights": "2654,2718,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21623277",
                    "mediaDataId": 0,
                    "title": "Biostatistics primer: what a clinician ought to know: hazard ratios.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21623277",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20860993",
                    "mediaDataId": 0,
                    "title": "Estimation of the 2-sample hazard ratio function using a semi parametric model.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20860993",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 369,
            "othersAvgTimeSpent": 94,
            "notes": null,
            "peopleTaken": 110229,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1571,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 7691,
            "questionIndex": 7691,
            "questionText": "<p><strong>Item 2 of 2</strong></p><p>At the end of the follow-up period, investigators reported that 17% of patients in the medical therapy group and 91% of patients in the medical therapy plus CABG group underwent CABG.&nbsp; Combining both groups and then analyzing outcomes for patients who actually underwent CABG versus those who received only medical therapy might introduce which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<p>The study presented in the abstract is a randomized clinical trial comparing the benefit of CABG with medical therapy versus medical therapy alone.&nbsp; Despite high-quality medical therapy provided to all patients in the study, 17% of patients in the medical therapy group clinically deteriorated to the point where CABG was uncontrovertibly indicated.&nbsp; When the treatment regimen selected for a patient depends on the severity of the patient&#39;s condition, a form of selection bias known as susceptibility bias (confounding by indication) can result.&nbsp; This occurs because surgery patients arising from the medical therapy group may have underlying confounders that were responsible for worsening of their disease.&nbsp; Grouping them with patients from the surgery group may lead to erroneous analysis and weaken the conclusions that can be drawn from the study.</p><p>To avoid selection bias in studies, patients are randomly assigned to treatments to minimize potential confounding variables.&nbsp; Many studies also perform an intention-to-treat (ITT) analysis to deal with selection bias.&nbsp; An ITT analysis compares the initial randomized treatment groups (the original intention) regardless of the eventual treatment to avoid counting crossover patients.&nbsp; Conversely, as-treated analysis (suggested in question stem) compares the groups based on the actual treatment received.&nbsp; An as-treated analysis is performed to gauge the effectiveness of the treatment itself, with less regard for potential confounders.</p><p><strong>(Choice A)</strong>&nbsp; Lead-time bias happens when two disease interventions are compared and one diagnoses the disease earlier than the other without an effect on the outcome (eg, survival).&nbsp; This would make it appear that the intervention prolonged survival when it really just diagnosed the disease sooner.</p><p><strong>(Choice B)</strong>&nbsp; Measurement bias occurs from poor data collection with inaccurate results (not described in this case).</p><p><strong>(Choice C)</strong>&nbsp; Observer bias occurs when the observer is influenced by prior knowledge or details of the study in a way that affects the results. &nbsp;Studies attempt to avoid this bias by blinding observers from knowing treatment assignments and by measuring objective outcomes (eg, mortality) that are less likely to be skewed by observers.&nbsp; Observer bias could potentially be present from the outset as this study was not blinded.&nbsp; However, changing the type of data analysis would not introduce this bias.</p><p><strong>(Choice D)</strong>&nbsp; Recall bias occurs when a study participant&#39;s answer to a question is affected by prior exposures.&nbsp; However, this is more common in retrospective studies rather than prospective studies such as randomized clinical trials.</p><p><strong>Educational objective:</strong><br>When the treatment regimen selected for a patient depends on the severity of the patient&#39;s condition, a form of selection bias known as susceptibility bias (confounding by indication) can result.&nbsp; To avoid selection bias in studies, patients are randomly assigned to treatments to minimize potential confounding variables.&nbsp; Many studies also perform an intention-to-treat analysis, which compares the initial randomized treatment groups (the original intention) regardless of the eventual treatment.</p>",
            "abstractId": 3,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24175,
            "topic": "Bias",
            "titleId": 24175,
            "title": "Bias",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 7690,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Lead-time bias",
                    "choiceNumber": 1,
                    "correctTaken": 12315,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Measurement bias",
                    "choiceNumber": 2,
                    "correctTaken": 24914,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observer bias",
                    "choiceNumber": 3,
                    "correctTaken": 6679,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recall bias",
                    "choiceNumber": 4,
                    "correctTaken": 2289,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Selection bias",
                    "choiceNumber": 5,
                    "correctTaken": 63801,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 3,
            "highlights": "380,575,true,-1,1*1102,1390,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "3994467",
                    "mediaDataId": 0,
                    "title": "The role of susceptibility bias in epidemiologic research.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/3994467",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 42,
            "othersAvgTimeSpent": 40,
            "notes": null,
            "peopleTaken": 109998,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 959,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 3989,
            "questionIndex": 3989,
            "questionText": "<p>A study was conducted to assess the relationship between serum HDL2 level (a subfraction of HDL) and carotid intima-media thickness as a marker of atherosclerosis.&nbsp; The results revealed a linear relationship between the 2 variables, with a correlation coefficient <em>r</em> = &#8722;0.25 (<em>p</em> = 0.005).&nbsp; Which of the following is the most appropriate conclusion about these results?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"35793\" src=\"https://www.uworld.com/media/highresdefault/L59668.png\"  ></p><p>The <strong>correlation coefficient</strong>&nbsp;<em><strong>r</strong></em> describes the <strong>direction</strong> (negative or positive) and the <strong>strength</strong> (values closer to &#8722;1 or 1 indicate stronger relationships) of the linear relationship between 2 quantitative variables:</p><ul><li><p><strong><em>r</em> &lt; 0</strong> indicates that, as <strong>one variable increases, the other variable decreases</strong>.&nbsp; This means that lower values of one variable tend to relate to higher values of the other variable, and vice versa.</p></li><li><p><strong><em>r</em> &gt; 0</strong> indicates that <strong>both variables increase (or decrease) together</strong>.&nbsp; This means that lower values of one variable tend to relate to lower values of the other variable, and vice versa.</p></li></ul><p>In this study, results revealed a linear relationship between levels of HDL2 and carotid intima-media thickness (correlation coefficient, <em>r</em> = &#8722;0.25; <em>p</em> = 0.005).&nbsp; The <strong>negative correlation</strong> coefficient (<em>r</em> = &#8722;0.25) suggests that <strong>higher levels of HDL2</strong> tend to <strong>relate to lower values</strong> of <strong>carotid intima-media thickness</strong> (and vice versa) <strong>(Choices C and E)</strong>.&nbsp; The <em>p</em>-value for the correlation coefficient (0.005) suggests that the relationship is <strong>statistically significant (Choice D)</strong>.&nbsp; However, a statistically significant correlation between 2 variables <strong>does not imply causation (Choice B)</strong>; it implies that the 2 variables are linearly related.</p><p><strong>Educational objective:</strong><br>The correlation coefficient <em>r</em> describes the direction (negative or positive) and the strength (values closer to &#8722;1 or 1 indicate stronger relationships) of the linear relationship between 2 quantitative variables.&nbsp; It does not imply causality.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 10618,
            "topic": "Correlation coefficient",
            "titleId": 10618,
            "title": "Correlation coefficient",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Higher levels of HDL2 tend to relate to lower values of carotid intima-media thickness",
                    "choiceNumber": 1,
                    "correctTaken": 12421,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lower levels of HDL2 cause carotid intima-media thickening",
                    "choiceNumber": 2,
                    "correctTaken": 313,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lower levels of HDL2 tend to relate to lower values of carotid intima-media thickness",
                    "choiceNumber": 3,
                    "correctTaken": 608,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The association between HDL2 level and carotid intima-media thickness is not statistically significant",
                    "choiceNumber": 4,
                    "correctTaken": 351,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There is a positive correlation between HDL2 level and carotid intima-media thickness",
                    "choiceNumber": 5,
                    "correctTaken": 365,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 108,
            "othersAvgTimeSpent": 41,
            "notes": null,
            "peopleTaken": 14058,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 88,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 112,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 18564,
            "questionIndex": 20035,
            "questionText": "<p>A 72-year-old woman diagnosed with osteoporosis and recovering from a recent vertebral fracture caused by a fall is concerned about future vertebral fractures.&nbsp; She reads a magazine article on how drug Z reduces the risk of new fractures in patients with osteoporosis by 60%.&nbsp; The report states that patients in the study were randomly assigned to either the new drug or placebo.&nbsp; The incidence of new fractures in the drug Z group was 10% whereas in the placebo group it was 25%.&nbsp; Which of the following was most likely presented as the 60% reduction in fractures?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34642\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\" style=\"width:40.0%\"><p align=\"center\"><strong>Common measures of therapeutic efficacy</strong></p></td></tr><tr><td style=\"width:20.0%\"><p align=\"center\"><strong>Term</strong></p></td><td style=\"width:40.0%\"><p align=\"center\"><strong>Definition</strong></p></td><td style=\"width:40.0%\"><p align=\"center\"><strong>Calculation</strong></p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Absolute risk reduction (ARR)</strong></p></td><td style=\"width:40.0%;\"><p>Percentage indicating the actual difference in event rate between control &amp; treatment groups</p></td><td style=\"width:40.0%;\"><p align=\"center\">ARR = control rate &ndash; treatment rate</p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Relative risk reduction (RRR)</strong></p></td><td style=\"width:40.0%;\"><p>Percentage indicating relative reduction in the treatment event rate compared to the control group</p></td><td style=\"width:40.0%;\"><p align=\"center\">RRR = ARR / control rate</p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Relative risk (RR)</strong></p></td><td style=\"width:40.0%;\"><p>Ratio of the probability of an event occurring in the treatment group compared to the control group</p></td><td style=\"width:40.0%;\"><p align=\"center\">RR = treatment rate / control rate</p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Number needed to treat (NNT)</strong></p></td><td style=\"width:40.0%;\"><p>Number of individuals who need to be treated to prevent a negative outcome in 1 patient</p></td><td style=\"width:40.0%;\"><p align=\"center\">NNT = 1 / ARR</p></td></tr></tbody></table></div><p><strong>Absolute risk reduction (ARR)</strong> describes the <strong>absolute difference in risk</strong> of an unfavorable outcome between the treatment group (eg, drug Z) and the control group (eg, placebo):</p><div style=\"margin-left: 3em;\"><p>ARR = (Risk<font size=\"2\"><sub>control</sub></font> &#8722; Risk<font size=\"2\"><sub>treatment</sub></font>)</p></div><p><strong>Relative risk reduction (RRR)</strong> describes the <strong>difference in risk</strong> of an unfavorable outcome between the treatment group and the control group <strong>relative to the control group</strong> and calculated as follows:</p><div style=\"margin-left: 3em;\"><p>RRR = ARR / Risk<font size=\"2\"><sub>control</sub></font></p></div><p>In this example, <strong>Risk</strong><font size=\"2\"><sub><strong>control</strong></sub></font> (ie, risk of new vertebral fracture in the placebo group) is 0.25 (or 25%), and <strong>Risk</strong><font size=\"2\"><sub><strong>treatment</strong></sub></font> (ie, risk of new vertebral fracture in the drug Z group) is 0.10 (or 10%).&nbsp; Therefore, ARR and RRR for new vertebral fractures among patients in the drug Z group are:</p><div style=\"margin-left: 3em;\"><p>ARR = 0.25 &#8722; 0.10 = 0.15 (or 15%) <strong>(Choice A)</strong></p><p>RRR = 0.15 / 0.25 = 0.60 (or 60%)</p></div><p>Alternately, RRR may be calculated using relative risk (RR):</p><div style=\"margin-left: 3em;\"><p>RRR = 1 &#8722; RR</p></div><p>For this example, RR is the ratio of the risk of new vertebral fractures in drug Z group to the risk of new vertebral fractures in the placebo group:</p><div style=\"margin-left: 3em;\"><p>RR = (Risk<font size=\"2\"><sub>treatment</sub></font> / Risk<font size=\"2\"><sub>control</sub></font>) = (0.10 / 0.25) = 0.40 <strong>(Choice D)</strong></p></div><p>Therefore, RRR = 1 &#8722; 0.40 = 0.60 (or 60%).</p><p>Advertisements sometimes report RRR rather than ARR to give the appearance of a more substantial effect, as in this case with 60% (relative) reduction as compared to 15% (absolute) reduction.</p><p>Note:&nbsp; The formula for RRR based on RR can be derived from the formula for RRR based on the difference in risks, as follows: RRR = (Risk<font size=\"2\"><sub>control</sub></font> &#8722; Risk<font size=\"2\"><sub>treatment</sub></font>) / Risk<font size=\"2\"><sub>control</sub></font> = 1 &#8722; (Risk<font size=\"2\"><sub>treatment</sub></font> / Risk<font size=\"2\"><sub>control</sub></font>) = 1 &#8722; RR.&nbsp; Risk<font size=\"2\"><sub>control</sub></font> and Risk<font size=\"2\"><sub>treatment</sub></font> are sometimes called the control and treatment rates, respectively.</p><p><strong>(Choice B)</strong>&nbsp; The number needed to treat (NNT) is the number of patients who need to be treated with a specific treatment (eg, drug Z) to prevent an additional negative event (eg, 1 fewer patients with a new vertebral fracture) when compared with a control group (eg, placebo).&nbsp; NNT is the inverse of the absolute risk reduction (ARR): NNT = 1 / ARR.&nbsp; In this study, NNT = 1 / 0.15 = 6.7 (or 7).</p><p><strong>(Choice C)</strong>&nbsp; The odds ratio measures the strength of the association between a risk factor (eg, smoker or nonsmoker) and an outcome/disease (eg, presence or absence of myocardial infarction) in case-control studies.</p><p><strong>Educational objective:</strong><br>Relative risk reduction (RRR) measures how much a treatment reduces the risk of an unfavorable outcome.&nbsp; RRR may be calculated using the absolute risk reduction (ARR) or the relative risk (RR):</p><ul><li><p>RRR = ARR / Risk<font size=\"2\"><sub>control</sub></font> = (Risk<font size=\"2\"><sub>control</sub></font> &#8722; Risk<font size=\"2\"><sub>treatment</sub></font>) / Risk<font size=\"2\"><sub>control</sub></font></p></li><li><p>RRR = 1 &#8722; RR</p></li></ul>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 15391,
            "topic": "Risk, rate, prevalence and incidence",
            "titleId": 15391,
            "title": "Risk, rate, prevalence and incidence",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Absolute risk reduction",
                    "choiceNumber": 1,
                    "correctTaken": 1215,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Number needed to treat",
                    "choiceNumber": 2,
                    "correctTaken": 329,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Odds ratio",
                    "choiceNumber": 3,
                    "correctTaken": 444,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Relative risk",
                    "choiceNumber": 4,
                    "correctTaken": 695,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Relative risk reduction",
                    "choiceNumber": 5,
                    "correctTaken": 7968,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20407271",
                    "mediaDataId": 0,
                    "title": "Measures of effect in epidemiological research.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20407271",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "17653136",
                    "mediaDataId": 0,
                    "title": "Measures of effect: relative risks, odds ratios, risk difference, and &#39;number needed to treat.&#39;",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/17653136",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 322,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 10651,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 177,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 20310,
            "questionIndex": 21809,
            "questionText": "<p>Over the course of 2 days, 25 elderly individuals came to the emergency department of an urban medical center with acute respiratory tract infection (ARTI)&mdash;mainly bronchiolitis or pneumonitis.&nbsp; Public health authorities investigated the outbreak and used standardized questionnaires to collect relevant clinical and sociodemographic information from the 25 individuals with ARTI and 50 elderly individuals without ARTI matched by age, sex, and county of residence.&nbsp; Preliminary results showed that 92% of the elderly individuals with ARTI had attended a social gathering the previous week, and 20% of the elderly individuals without ARTI had attended the same social gathering.&nbsp; Which of the following statements is correct about this study design?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"6804\" src=\"https://www.uworld.com/media/L13767.jpg\" ></p><p>In this study, elderly patients with acute respiratory tract infection <strong>(ARTI) are cases</strong> (individuals with disease), and elderly patients with <strong>no ARTI are controls</strong> (individuals with no disease).&nbsp; A questionnaire was used to collect relevant clinical and sociodemographic information to <strong>compare exposure</strong> to <strong>&#8805;1 risk factors</strong> of interest (ie, attendance at social gatherings) between cases and controls.</p><p>Because individuals were initially selected based on their status for a particular disease (ie, case: ARTI; control: no ARTI) and then categorized based on past exposure to a risk factor (ie, attendance at a social gathering), the study has a <strong>case-control design</strong>.</p><p><strong>(Choice A)</strong>&nbsp; In a randomized controlled trial (RCT), participants are randomly assigned to &#8805;1 interventions to evaluate the effects of those interventions on outcomes of interest.&nbsp; Participants in a RCT may or may not be matched by certain characteristics (eg, age, sex, residence) to control for confounders.&nbsp; However, this study does not involve comparing treatments.</p><p><strong>(Choice B)</strong>&nbsp; In a cross-sectional study, a snapshot of a population is taken to estimate the prevalence of risk factors and disease simultaneously.&nbsp; A questionnaire is often used to collect data in cross-sectional studies, but they are also common in other study designs (eg, case-control study).</p><p><strong>(Choice D)</strong>&nbsp; In a cohort study, 2 groups of individuals are initially identified as &#x22;exposed&#x22; or &#x22;nonexposed&#x22; according to their exposure status to a specific risk factor and then followed over time to assess development of the outcome (ie, incidence of disease).&nbsp; In this study, individuals were initially identified according to disease status (not exposure status); therefore, it is a case-control study, meaning that it is not possible to estimate incidence of disease.</p><p><strong>(Choice E)</strong>&nbsp; In a case series, a small group of patients with a similar diagnosis or treatment is described at a point in time or followed over a certain period.&nbsp; This observational study has no comparison group, so it cannot establish associations between risk factors and disease.&nbsp; However, in this study there is a comparison group and an implicit purpose to evaluate association between exposure (ie, social gathering) and disease (ie, ARTI).</p><p><strong>Educational objective:</strong><br>Case-control studies can consider only 1 outcome (ie, disease) per study but can evaluate exposure to &#8805;1 risk factors.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 19502,
            "topic": "Study designs",
            "titleId": 19502,
            "title": "Study designs",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Because individuals with and without ARTI were matched by age, sex, and county of residence, this study is a randomized controlled trial",
                    "choiceNumber": 1,
                    "correctTaken": 97,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Because it collected data on attendance at the social gathering and presence of ARTI using a standardized questionnaire, this study is a cross-sectional study",
                    "choiceNumber": 2,
                    "correctTaken": 1835,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Because it compares information about attendance at the social gathering among individuals with and without ARTI, this study is a case-control study",
                    "choiceNumber": 3,
                    "correctTaken": 7386,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Because it compares the incidence of disease among elderly individuals who attended the social gathering and those who did not, this study is a cohort study",
                    "choiceNumber": 4,
                    "correctTaken": 928,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Because it describes individuals with and without ARTI in terms of clinical and sociodemographic characteristics, this study is a case series",
                    "choiceNumber": 5,
                    "correctTaken": 453,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1844,1994,true,-1,1*2019,2043,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 183,
            "othersAvgTimeSpent": 90,
            "notes": null,
            "peopleTaken": 10699,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 384,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 18897,
            "questionIndex": 20376,
            "questionText": "<p>A 31-year-old woman brings her 18-month-old son to the pediatrician for a well-baby checkup.&nbsp; She is extremely concerned that her child has been gaining weight at an accelerated pace.&nbsp; She asks how her son&#39;s risk of developing childhood obesity before his early school-age years compares with that of children who gain weight at a normal pace.&nbsp; Which of the following types of study designs would best answer her question?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"6804\" src=\"https://www.uworld.com/media/L13767.jpg\" ></p><p><strong>Observational studies</strong> are broadly classified as having a descriptive or analytic design.</p><ul><li><p><strong>Descriptive designs</strong> (eg, case report, case series, cross-sectional) describe patterns of disease in populations by time, place, and person.&nbsp; These studies help <strong>generate hypotheses</strong> about associations between risk factors and disease, such as in a study showing that a high proportion of people with lung cancer are also smokers.</p></li><li><p><strong>Analytical designs</strong> (eg, case-control, cohort, some cross-sectional designs) <strong>test hypotheses</strong> about associations between risk factors and disease, such as in a study that determines that smoking is a statistically significant risk factor for lung cancer.</p></li></ul><p>The choice of study design to address a specific research question is guided by a study&#39;s objective, the disease of interest, its apparent association to risk factors, and feasibility constraints.</p><p>In this question, the mother of an 18-month-old child who seems to be gaining weight at an accelerated pace is concerned about her child&#39;s risk of developing childhood obesity compared with that of children who gain weight at a normal pace.&nbsp; This suggests that the mother identifies the <strong>accelerated weight gain</strong> in young children as a potential <strong>risk factor</strong> for <strong>childhood obesity</strong>.&nbsp; To answer the mother&#39;s question, the study design would have to <strong>test a hypothesis</strong> about the <strong>association</strong> between a risk factor (eg, accelerated weight gain in young children) and disease (eg, childhood obesity).&nbsp; Therefore, the study must have an <strong>analytical design (Choices B and C)</strong>.&nbsp; The analytical study design that <strong>compares the risk of developing disease</strong> (eg, childhood obesity) between <strong>exposed</strong> (eg, young children with accelerated weight gain) and <strong>nonexposed</strong> (eg, young children with normal weight gain) groups is the <strong>cohort study</strong>.</p><p><strong>(Choice A)</strong>&nbsp; A case-control study is an analytical design in which potential participants are initially identified based on disease status as cases (ie, with disease) or controls (ie, without disease).&nbsp; Once cases and controls are identified, the presence of past exposure to &#8805;1 risk factors of interest is determined in each group.&nbsp; Because cases, by definition, already have the disease, case-control studies cannot calculate and compare risk of developing disease.</p><p><strong>(Choice E)</strong>&nbsp; A cross-sectional study takes a snapshot of a population to estimate the prevalence of risk factors and disease simultaneously, so this study design cannot calculate and compare risk of developing disease.</p><p><strong>Educational objective:</strong><br>A cohort study is an analytical study design that estimates and compares the risk of developing disease between exposed and nonexposed groups.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 19502,
            "topic": "Study designs",
            "titleId": 19502,
            "title": "Study designs",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Case-control study",
                    "choiceNumber": 1,
                    "correctTaken": 2122,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Case report",
                    "choiceNumber": 2,
                    "correctTaken": 94,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Case series",
                    "choiceNumber": 3,
                    "correctTaken": 208,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cohort study",
                    "choiceNumber": 4,
                    "correctTaken": 7557,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cross-sectional study",
                    "choiceNumber": 5,
                    "correctTaken": 593,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "704,900,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 86,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 10574,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 892,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 3880,
            "questionIndex": 3880,
            "questionText": "A new screening test was devised to detect pancreatic cancer at early stages using a serum marker (CA19-9) of the disease.&nbsp; A study of this new test showed that its use prolongs the survival of patients with pancreatic cancer by several months.&nbsp; The researchers concluded that use of the test improves the prognosis of patients with pancreatic cancer.&nbsp; Which of the following is a potential problem with this conclusion?",
            "questionHeader": "",
            "explanationText": "<p>Lead-time bias should always be considered while evaluating any screening test.&nbsp; This bias occurs when there is an incorrect assumption or conclusion of prolonged apparent survival and better prognosis due to a screening test.&nbsp; What actually happens is that detection of the disease was made at an earlier point in time, but the disease course itself or the prognosis did not change, so the screened patients appeared to live longer from the time of diagnosis to the time of death.&nbsp; (USMLE tip: think of lead-time bias when you see &#x22;a new screening test&#x22; for poor prognosis diseases like lung or pancreatic cancer.)</p><p><strong>(Choices A, B and E)</strong>&nbsp; Observer&#39;s bias, measurement bias and ascertainment bias refer to misclassification of an outcome and/or exposure (e.g., labeling diseased subjects as non-diseased and vice versa) and are related to the design of the study.&nbsp; The scenario described does not mention how the study was designed.</p><p><strong>(Choice D)</strong>&nbsp; Although the results of the study could be potentially confounded, there is no information on how potential confounders were treated during the design or analysis stage of this study.</p><p><strong>Educational Objective:</strong><br>Understand the concept of lead-time bias in screening tests.&nbsp; The typical example of lead-time bias is prolongation of apparent survival in patients to whom a test is applied, without changing the prognosis of the disease.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24175,
            "topic": "Bias",
            "titleId": 24175,
            "title": "Bias",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Observer&#39;s bias",
                    "choiceNumber": 1,
                    "correctTaken": 8961,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Measurement bias",
                    "choiceNumber": 2,
                    "correctTaken": 10168,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lead-time bias",
                    "choiceNumber": 3,
                    "correctTaken": 251825,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Confounding",
                    "choiceNumber": 4,
                    "correctTaken": 12428,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ascertainment bias",
                    "choiceNumber": 5,
                    "correctTaken": 11054,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "513,645,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 66,
            "othersAvgTimeSpent": 25,
            "notes": null,
            "peopleTaken": 294436,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 86,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 327,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 19985,
            "questionIndex": 21475,
            "questionText": "<p>A student conducts a case-control study to evaluate hypertension as a risk factor for breast cancer in women.&nbsp; Cases (<em>n</em> = 20) are defined as women with a histopathologically confirmed primary breast cancer who are recruited within 2 months of diagnosis (incident cases).&nbsp; Controls (<em>n</em> = 20) are defined as women who have no evidence of malignancy in images during screening mammography completed 6 months prior to recruitment and who have no personal history of breast cancer.&nbsp; Blood pressure &#8805;140/90 mm Hg is used as a cutoff point to identify patients as hypertensive.&nbsp; The student estimates an odds ratio of 4.0 (95% confidence interval: 1.75-9.12) and concludes that women with hypertension have a 4-fold greater risk of breast cancer than women without hypertension.&nbsp; Based on this information, which of the following describes the reason that the student&#39;s conclusion is incorrect?</p>",
            "questionHeader": "",
            "explanationText": "<p>In this <strong>case-control study</strong>, cases are women with breast cancer and controls are women without breast cancer; the exposure is hypertension.</p><p>Because cases in a case-control study already have the disease, this study design <strong>cannot calculate the risk of disease</strong>; instead, it compares <strong>odds of exposure</strong> between cases and controls.&nbsp; The odds of an event are related to the risk, or probability (<em>P</em>), of that event: odds = <em>P</em> / (1 &#8722; <em>P</em>).&nbsp; For example, the probability (ie, risk) of rolling a die and getting a 1 is 1/6, but the odds of rolling a 1 are 1/5.</p><p>The measure of association between exposure and disease in case-control studies is the <strong>odds ratio (OR)</strong>:</p><p style=\"text-align: center;\">OR = (odds of exposure in cases) / (odds of exposure in controls)</p><p>The OR is sometimes described as odds of disease among exposed patients relative to nonexposed patients; these two definitions are mathematically equivalent.</p><p>The estimated association <strong>OR = 4.0</strong> means that women with breast cancer have <strong>4 times greater odds</strong> (rather than risk) for hypertension than women with no breast cancer.&nbsp; Because the 95% confidence interval (CI) of the OR (1.75-9.12) excludes the null value (ie, OR = 1), the results are statistically significant <strong>(Choice A)</strong>.&nbsp; Therefore, the student&#39;s conclusion is incorrect because the <strong>measure of effect</strong> (ie, OR) is <strong>erroneously interpreted</strong> in terms of <strong>risk (rather than odds)</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Because the CI of the OR is constructed around the sample OR (eg, OR = 4.0), it always includes the sample OR (eg, 0.5-29.1).</p><p><strong>(Choice C)</strong>&nbsp; One interpretation of the confidence level of a CI (eg, 95%, 99%) is that it refers to how often a CI includes the true value of a population parameter (eg, OR) if the process is repeated multiple times.&nbsp; There is no correct or incorrect confidence level; its value is specified prior to data analysis based on the precision level desired to estimate the population parameter.</p><p><strong>Educational objective:</strong><br>The odds ratio (OR) is a measure of association in case-control studies to compare the odds of exposure in cases relative to controls.&nbsp; The OR is not a direct measure of risk.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 5925,
            "topic": "Case control studies",
            "titleId": 5925,
            "title": "Case control studies",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Because the association is not shown to be statistically significant",
                    "choiceNumber": 1,
                    "correctTaken": 612,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Because the confidence interval for the odds ratio includes 4.0",
                    "choiceNumber": 2,
                    "correctTaken": 602,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Because the confidence level used is incorrect",
                    "choiceNumber": 3,
                    "correctTaken": 504,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Because the measure of effect is not a direct measure of risk",
                    "choiceNumber": 4,
                    "correctTaken": 8830,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 61,
            "othersAvgTimeSpent": 80,
            "notes": null,
            "peopleTaken": 10548,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 84,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 574,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 19024,
            "questionIndex": 20507,
            "questionText": "<p>A single-blind randomized controlled trial is conducted to determine whether a novel treatment for moderate to severe (ie, not controlled adequately by topical therapies) eczema is more effective than dupilumab in reducing the clinical symptoms.&nbsp; Eighty adults with moderate to severe eczema are randomly assigned to receive the new treatment or dupilumab every 2 weeks for 16 weeks.&nbsp; Treatment effectiveness is based on physician and patient reports of symptom improvement.&nbsp; Results based on physicians&#39; reports suggest that the novel treatment is more effective than dupilumab in improving symptoms (<em>p</em> = 0.02).&nbsp; Results based on patients&#39; reports suggest that the novel treatment is as effective as dupilumab in improving symptoms (<em>p</em> = 0.15).&nbsp; Which of the following is of greatest potential concern in this study?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Observers</strong> (eg, researchers, physicians) in a study may introduce bias by <strong>misclassifying data</strong> (eg, treatment outcomes) due to individual differences in interpretation or preconceived expectations regarding the treatment.&nbsp; This type of bias is known as <strong>observer bias</strong>.&nbsp; It is a concern in <strong>single-blind studies</strong>, in which individuals observing outcomes are aware of treatment assignments, and in studies that rely on <strong>subjective outcomes</strong> (eg, symptoms improvement).</p><p>This question describes a single-blind study in which <strong>physicians</strong> responsible for reporting <strong>subjective outcomes</strong> (ie, eczema symptoms improvement) were <strong>unblinded</strong> to (aware of) treatment assignments whereas participants were blinded to (unaware of) treatment assignment.&nbsp; Study results based on physicians&#39; reports show that the novel treatment is more effective; however, study results based on patients&#39; reports show that the treatments are equally effective.&nbsp; These results suggest that a <strong>preconceived expectation</strong> regarding the novel treatment and knowledge of treatment assignment may have led some physicians to <strong>overestimate</strong> symptoms <strong>improvement</strong> and <strong>effectiveness</strong> of the novel treatment compared to dupilumab.&nbsp; This is an example of observer bias.</p><p><strong>(Choice A)</strong>&nbsp; An unequal loss of participants from study groups in follow-up (eg, cohort, experimental) studies is known as attrition bias.&nbsp; The study in this question provides no information to evaluate attrition.</p><p><strong>(Choice B)</strong>&nbsp; Inaccurate recollection of past events, known as recall bias, is a potential problem for case-control studies (not randomized controlled trials), particularly when questionnaires are used to ask participants about distant past exposure.</p><p><strong>(Choice C)</strong>&nbsp; Effect modification occurs when an external variable differentially modifies (positively or negatively) the effect of a treatment on the outcome of interest in different groups.&nbsp; In this study, participants were randomly assigned to treatments, so effect modification by age is very unlikely.</p><p><strong>(Choice E)</strong>&nbsp; The study evaluates a novel treatment for moderate to severe eczema.&nbsp; Therefore, a sample composed of patients with moderate to severe eczema is adequate and not a concern in this study.</p><p><strong>Educational objective:</strong><br>Observer bias occurs when observers (eg, researchers, physicians) misclassify data (eg, treatment outcomes) due to preconceived expectations regarding the treatment.&nbsp; This type of bias may lead to an underestimation or overestimation of a treatment effect.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24175,
            "topic": "Bias",
            "titleId": 24175,
            "title": "Bias",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Many severe cases were lost to follow-up only in the novel treatment group",
                    "choiceNumber": 1,
                    "correctTaken": 257,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Patients had an inaccurate recollection of the effectiveness of the treatment",
                    "choiceNumber": 2,
                    "correctTaken": 858,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The effect of the treatment is different for different age groups",
                    "choiceNumber": 3,
                    "correctTaken": 134,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The outcome in this specific study design is subjective in nature",
                    "choiceNumber": 4,
                    "correctTaken": 9129,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The study only included patients with moderate to severe eczema",
                    "choiceNumber": 5,
                    "correctTaken": 189,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 198,
            "othersAvgTimeSpent": 80,
            "notes": null,
            "peopleTaken": 10567,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 86,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 401,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 18739,
            "questionIndex": 20214,
            "questionText": "<p>A recent study evaluated whether a combination of folic acid, vitamin B<font size=\"2\"><sub>6</sub></font>, and vitamin B<font size=\"2\"><sub>12</sub></font> affects the risk of cardiovascular events among women at high risk for cardiovascular disease (CVD).&nbsp; Women age &gt;45 with either a history of CVD or &#8805;3 coronary risk factors were randomized to groups receiving a combination pill containing folic acid, vitamin B<font size=\"2\"><sub>6</sub></font>, and vitamin B<font size=\"2\"><sub>12</sub></font> (treatment group) or a matching placebo (placebo group) and were followed for 10 years.&nbsp; The main outcome of the study was occurrence of any of the following cardiovascular events: myocardial infarction (MI), stroke, or cardiovascular death.&nbsp; The rate of the composite outcome was 114.6 per 100,000 person-years in the treatment group and 118.6 per 100,000 person-years in the placebo group for a relative risk of 0.97 (95% confidence interval of 0.80-1.18).&nbsp; Which of the following conclusions can be drawn from this study?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Relative risk (RR)</strong> is commonly used in cohort and experimental studies as the measure of <strong>association</strong> between the exposure to a risk factor or <strong>treatment</strong> and an <strong>outcome</strong> or disease.&nbsp; RR is the risk (or rate) of an outcome or disease (eg, myocardial infarction [MI], stroke, or cardiovascular death) in the exposed group (eg, combination pill of folic acid, vitamin B<font size=\"2\"><sub>6</sub></font>, and vitamin B<font size=\"2\"><sub>12</sub></font>) divided by the risk (or rate) of the same outcome or disease in the nonexposed group (eg, placebo).</p><p style=\"text-align:center;\">RR = (rate of outcome in exposed group) / (rate of outcome in nonexposed group)</p><p>The RR may be interpreted as follows:</p><ul><li>RR &lt;1.0 indicates that the exposure decreases the risk of outcome.</li><li>RR = 1.0 (null value) indicates that the exposure has no effect on the risk of outcome.</li><li>RR &gt;1.0 indicates that the exposure increases the risk of outcome.</li></ul><p>The confidence interval (CI) of a given RR indicates, with a certain confidence level (eg, 95%), whether the RR is statistically different from the null value (ie, RR = 1.0).&nbsp; A CI that <strong>includes the null value</strong> (ie, RR = 1.0) is <strong>not statistically significant</strong>, and a CI that excludes the null value&nbsp;is statistically significant.</p><p>In this study, the <strong>RR for MI, stroke, or cardiovascular death</strong> (ie, outcome) among women receiving a combination pill containing folic acid, vitamin B<font size=\"2\"><sub>6</sub></font>, and vitamin B<font size=\"2\"><sub>12</sub></font> (ie, exposed) compared to women receiving placebo (ie, nonexposed) is 0.97 (95% CI: 0.80-1.18).&nbsp; The <strong>CI includes the null value</strong> (ie, RR = 1.0); therefore, there is <strong>no association</strong> between the treatment and the outcome.&nbsp; This means that the <strong>study failed to show</strong> that the <strong>treatment has an effect</strong> on the risk of cardiovascular events <strong>(Choices A and D)</strong>.</p><p><strong>(Choices B and C)</strong>&nbsp; The rate of MI, stroke, or cardiovascular death is 114.6 per 100,000 person-years in the treatment group and 118.6 per 100,000 person-years in the placebo group.</p><p><strong>Educational objective:</strong><br>A relative risk (RR) &lt;1.0 indicates a lower risk for the outcome in the treatment group; a RR = 1.0 indicates no association between treatment and outcome; and a RR &gt;1.0 indicates a greater risk for the outcome in the treatment group.&nbsp; A confidence interval (CI) that includes the null value for RR (ie, RR = 1.0) is not statistically significant, and a CI that excludes the null value (ie, RR = 1.0) is statistically significant.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 29979,
            "topic": "Measures of association",
            "titleId": 29979,
            "title": "Measures of association",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "The combination pill reduced the risk of cardiovascular death by 97%",
                    "choiceNumber": 1,
                    "correctTaken": 78,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The placebo group had 4% more events than the treatment group",
                    "choiceNumber": 2,
                    "correctTaken": 165,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The rate of MI, stroke, or cardiovascular death in both groups was 3%",
                    "choiceNumber": 3,
                    "correctTaken": 134,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The treatment group had a significantly lower risk of cardiovascular events compared to the placebo group",
                    "choiceNumber": 4,
                    "correctTaken": 523,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The study failed to show that the treatment has an effect on the risk of cardiovascular events",
                    "choiceNumber": 5,
                    "correctTaken": 9688,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 324,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 10588,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 91,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 451,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 19834,
            "questionIndex": 21323,
            "questionText": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td id=\"vignettedescriptor\">The drug ad applies to the next <strong>2</strong> items.</td></tr></tbody></table><p>A 59-year-old woman comes to the office for follow-up.&nbsp; The patient has hypertension, type 2 diabetes, and chronic kidney disease.&nbsp; Blood pressure is 150/95 mm Hg.&nbsp; BMI is 29.4 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination is unremarkable.&nbsp; Laboratory studies show elevated fasting lipid levels, including LDL cholesterol.</p><p><strong>Item 1 of 2</strong></p><p>Based on the drug ad, which of the following conclusions is most appropriate when considering the care of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Hazard ratio (HR)</strong> is the <strong>hazard rate</strong> of an event (eg, composite cardiovascular event) in the <strong>intervention group</strong> (eg, toraflozin) <strong>divided</strong> by the hazard rate of the same event in the <strong>control group</strong> (eg, placebo).&nbsp; HR is determined as follows:</p><p style=\"text-align:center;\"><strong>HR</strong> = (hazard rate in the intervention group) / (hazard rate in the control group)</p><p>The hazard rate represents the probability that an individual experiences an event at a particular point after the intervention, assuming this individual has survived to that point without experiencing any event.</p><p>The HR is interpreted as follows:</p><ul><li><p><strong>HR &lt; 1.0:</strong>&nbsp; At any time, the hazard rate of the event is lower in the intervention group than in the control group (ie, a smaller proportion of patients in the intervention group are experiencing an event compared to the control group).</p></li><li><p><strong>HR = 1.0 (null value):</strong>&nbsp; At any time, the hazard rate of the event is the same in both groups.</p></li><li><p><strong>HR &gt; 1.0:</strong>&nbsp; At any time, the hazard rate of the event is greater in the intervention group than in the control group.</p></li></ul><p>A confidence interval (CI) that includes the null value is not statistically significant, and a CI that excludes the null value is statistically significant.</p><p>In this study, the toraflozin group had an <strong>HR</strong> for a <strong>composite cardiovascular event</strong>&nbsp;(eg, cardiovascular deaths, hospitalizations, and urgent care visits) of <strong>0.75 (95% CI: 0.63-0.88)</strong> compared to the placebo group.&nbsp; Given an <strong>HR &lt; 1.0</strong> with a <strong>CI</strong> that <strong>excludes the null value</strong>, significantly fewer patients in the toraflozin group experienced a cardiovascular event than those in the placebo group.&nbsp; Because an HR = 0.75 suggests that toraflozin reduces the risk for a composite cardiovascular event by 1.0 &#8722; 0.75 = 0.25 (or 25%), this patient may benefit from toraflozin <strong>(Choice A)</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Toraflozin was significantly associated with a&nbsp;risk of serious adverse effects, but no information is given about the magnitude of the association.&nbsp; Although 480 / 640 = 75%, this refers to the composite cardiovascular events rather than the adverse effects (eg, diabetic ketoacidosis).</p><p><strong>(Choice C)</strong>&nbsp; The absolute difference in events (640 &#8722; 480 = 160) refers to the composite cardiovascular events, which include cardiovascular deaths, hospitalizations, and urgent care visits.&nbsp; A hospitalization would count as an event even in the absence of cardiovascular death; therefore, it cannot be stated that there were 160 more cardiovascular deaths in the placebo group.</p><p><strong>Educational objective:</strong><br>Hazard ratio (HR) measures the effect of an intervention on an outcome over time.&nbsp; A confidence interval for the HR that excludes the null value (HR = 1.0) is statistically significant.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 29979,
            "topic": "Measures of association",
            "titleId": 29979,
            "title": "Measures of association",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 19834,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Compared to placebo, toraflozin may significantly reduce the risk of cardiovascular deaths, hospitalizations, and urgent care visits by 75%",
                    "choiceNumber": 1,
                    "correctTaken": 561,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Patients taking toraflozin are approximately 75% more likely to develop diabetic ketoacidosis than patients taking placebo",
                    "choiceNumber": 2,
                    "correctTaken": 305,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There were 160 more cardiovascular deaths in the placebo group than in the toraflozin group",
                    "choiceNumber": 3,
                    "correctTaken": 299,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Treating patients with toraflozin may be beneficial in decreasing the risk of the composite event by 25% compared to placebo",
                    "choiceNumber": 4,
                    "correctTaken": 5617,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 2,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": {
                "id": 44831,
                "fileName": "L70427.jpg",
                "typeId": 1,
                "title": "Drug ad - TORAFLOZIN",
                "sequenceId": 1,
                "active": true,
                "baseUrl": "https://apps.uworld.com/media/"
            },
            "timeSpent": 299,
            "othersAvgTimeSpent": 97,
            "notes": null,
            "peopleTaken": 6782,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 83,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 665,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 19835,
            "questionIndex": 21324,
            "questionText": "<p><strong>Item 2 of 2</strong></p><p>Considering the data in the drug ad, how many patients with type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors need to be treated with toraflozin to prevent 1 additional cardiovascular death, hospitalization, or urgent care visit&nbsp;as compared to placebo?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34642\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\" style=\"width:40.0%\"><p align=\"center\"><strong>Common measures of therapeutic efficacy</strong></p></td></tr><tr><td style=\"width:20.0%\"><p align=\"center\"><strong>Term</strong></p></td><td style=\"width:40.0%\"><p align=\"center\"><strong>Definition</strong></p></td><td style=\"width:40.0%\"><p align=\"center\"><strong>Calculation</strong></p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Absolute risk reduction (ARR)</strong></p></td><td style=\"width:40.0%;\"><p>Percentage indicating the actual difference in event rate between control &amp; treatment groups</p></td><td style=\"width:40.0%;\"><p align=\"center\">ARR = control rate &ndash; treatment rate</p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Relative risk reduction (RRR)</strong></p></td><td style=\"width:40.0%;\"><p>Percentage indicating relative reduction in the treatment event rate compared to the control group</p></td><td style=\"width:40.0%;\"><p align=\"center\">RRR = ARR / control rate</p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Relative risk (RR)</strong></p></td><td style=\"width:40.0%;\"><p>Ratio of the probability of an event occurring in the treatment group compared to the control group</p></td><td style=\"width:40.0%;\"><p align=\"center\">RR = treatment rate / control rate</p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Number needed to treat (NNT)</strong></p></td><td style=\"width:40.0%;\"><p>Number of individuals who need to be treated to prevent a negative outcome in 1 patient</p></td><td style=\"width:40.0%;\"><p align=\"center\">NNT = 1 / ARR</p></td></tr></tbody></table></div><p>The <strong>number needed to treat (NNT)</strong> is the number of patients who need to be treated with a specific drug (eg, toraflozin) to <strong>prevent an additional negative event</strong> (eg, cardiovascular death, hospitalization, urgent care visit for heart failure [cardiovascular event]) when compared with a control group (eg, placebo).&nbsp; NNT is the <strong>inverse</strong> of the <strong>absolute risk reduction (ARR)</strong>:</p><p style=\"text-align:center;\">NNT = 1 / ARR</p><p>The ARR describes the difference in risk of an unfavorable event between a treatment group and a control group:</p><p style=\"text-align:center;\">ARR = (Risk<font size=\"2\"><sub>control</sub></font> &#8722; Risk<font size=\"2\"><sub>treatment</sub></font>)</p><p>In this question, 640 of 8,000 patients in the control (placebo) group developed a cardiovascular event, so <strong>Risk</strong><font size=\"2\"><sub><strong>control</strong></sub></font>&nbsp;<strong>is 640 / 8,000 = 0.08</strong>.&nbsp; In the treatment (toraflozin) group, 480 of 8,000 patients developed a cardiovascular event, so <strong>Risk</strong><font size=\"2\"><sub><strong>treatment</strong></sub></font>&nbsp;<strong>is 480 / 8,000 = 0.06</strong>.&nbsp; Therefore, the ARR for development of a cardiovascular event in the treatment group is:</p><p style=\"text-align:center;\">ARR = (Risk<font size=\"2\"><sub>control</sub></font> &#8722; Risk<font size=\"2\"><sub>treatment</sub></font>) = (0.08 &#8722; 0.06) = 0.02</p><p>The NNT is then calculated:</p><p style=\"text-align:center;\">NNT = 1 / ARR = 1 / 0.02 = 50</p><p>Therefore, <strong>approximately 50 patients</strong> need to be treated with toraflozin to prevent 1 additional cardiovascular death, hospitalization, or urgent care visit for heart failure as compared to placebo.&nbsp; NNT values allow comparisons between different interventions; in general, lower NNT values are preferred.</p><p><strong>Educational objective:</strong><br>The number needed to treat (NNT) is the number of patients who need to receive a treatment to prevent 1 additional negative event.&nbsp; NNT is the inverse of the absolute risk reduction.&nbsp; The lower the NNT, the more effective the treatment because fewer patients need to be treated to prevent 1 additional negative event.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 1652,
            "topic": "Number Needed To Treat",
            "titleId": 1652,
            "title": "Number Needed To Treat",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 19834,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "2",
                    "choiceNumber": 1,
                    "correctTaken": 584,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "6",
                    "choiceNumber": 2,
                    "correctTaken": 709,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "8",
                    "choiceNumber": 3,
                    "correctTaken": 550,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "25",
                    "choiceNumber": 4,
                    "correctTaken": 725,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "50",
                    "choiceNumber": 5,
                    "correctTaken": 4196,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 2,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": {
                "id": 44831,
                "fileName": "L70427.jpg",
                "typeId": 1,
                "title": "Drug ad - TORAFLOZIN",
                "sequenceId": 1,
                "active": true,
                "baseUrl": "https://apps.uworld.com/media/"
            },
            "timeSpent": 159,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 6764,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 408,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 3653,
            "questionIndex": 3653,
            "questionText": "<P>A study was conducted to evaluate the efficacy of a new antiviral drug for the treatment of the common cold in young children.&nbsp; The study population consisted of 100 children between the age of 2 to 8 years.&nbsp; These children were diagnosed with rhinovirus infection and subsequently given the particular antiviral drug.&nbsp; One week later, it was observed that 92 of the 100 patients were asymptomatic.&nbsp; Which of the following is the true conclusion of this study?</P>",
            "questionHeader": "",
            "explanationText": "<P>It is very important to consider the natural history of a disease when evaluating any drug trial.&nbsp; The common cold is a self-limiting disease, which generally resolves within a week.&nbsp; For this reason, conclusions are difficult to draw regarding the effectiveness of the drug.&nbsp; The resolution of symptoms in the 90% of the study population may be due to natural resolution rather than the drug.&nbsp; For such drug trials, a control group is useful since it helps exclude the bias due to natural resolution of the disease.</P><P><STRONG>(Choices A, B and D)</STRONG> It is difficult to comment on the effectiveness of the drug, unless a comparison is made with the control group and statistical significance is calculated to know the power of the study.</P><P><STRONG>(Choice E)</STRONG> The reason why no conclusion can be made is the absence of a control group in the study design, rather than improper patient compliance.&nbsp; Nevertheless, it is important to consider the level of compliance in a drug study done on small children.</P><P><STRONG>Educational objective:</STRONG><BR>Consider the natural history of a disease when evaluating the effectiveness of a drug in a trial.</P>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24175,
            "topic": "Bias",
            "titleId": 24175,
            "title": "Bias",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "The drug is highly effective as the effectiveness is 90%",
                    "choiceNumber": 1,
                    "correctTaken": 5096,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The drug is moderately effective as the efficacy is 90%",
                    "choiceNumber": 2,
                    "correctTaken": 3090,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "An exact conclusion cannot be drawn from the study, as common cold is often a self-limiting disease of less than 1 week",
                    "choiceNumber": 3,
                    "correctTaken": 277453,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The drug is not effective as the sample size is very small",
                    "choiceNumber": 4,
                    "correctTaken": 4698,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No conclusion can be made, as compliance is generally very low in small children",
                    "choiceNumber": 5,
                    "correctTaken": 1978,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 63,
            "othersAvgTimeSpent": 41,
            "notes": null,
            "peopleTaken": 292315,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 95,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 144,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 4182,
            "questionIndex": 4182,
            "questionText": "A case-control study was conducted to assess the relationship between alcohol consumption and breast cancer.&nbsp; First, the investigators interviewed patients with breast cancer.&nbsp; They then selected the neighbors of the patients with the same age and race, and used them as controls.&nbsp; Such study design helps to control which of the following problems?",
            "questionHeader": "",
            "explanationText": "<p>Matching is an efficient method to control <strong>confounding</strong>.&nbsp; It is frequently used in case-control studies.&nbsp; The initial step involves the selection of matching variables, which should always be the potential confounders (e.g., age, race).&nbsp; Cases and controls are then selected based on the matching variables, such that both groups have a similar distribution in accordance with the variables.</p><p>In this scenario, neighborhood &#x22;controls&#x22; were matched to &#x22;cases&#x22; by age and race.&nbsp; Selecting neighbors as controls has another advantage of <strong>matching</strong> the cases to controls by variables that are difficult to measure (e.g., socioeconomic status).</p><p><strong>(Choice A)</strong>&nbsp; Selection bias is not controlled by matching, because the controls selected may not reflect the exposure experience (in this case, alcohol consumption) of the general population.</p><p><strong>(Choices B, C and D)</strong>&nbsp; Recall bias, observer&#39;s bias, and ascertainment bias result from mislabeling exposed/unexposed or cases/controls.&nbsp; These are not affected by matching.</p><p><strong>Educational objective:</strong><br>Matching is frequently used in case-control studies because it is an efficient method to control confounding.&nbsp; Remember: matching variables should always be the potential confounders of the study (e.g., age, race).&nbsp; Cases and controls are then selected based on the matching variables, such that both groups have a similar distribution in accordance with the variables.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 6409,
            "topic": "Confounding, effect modification, bias, errors",
            "titleId": 6409,
            "title": "Confounding, effect modification, bias, errors",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Selection bias",
                    "choiceNumber": 1,
                    "correctTaken": 121627,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recall bias",
                    "choiceNumber": 2,
                    "correctTaken": 11400,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observer&#39;s bias",
                    "choiceNumber": 3,
                    "correctTaken": 9828,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ascertainment bias",
                    "choiceNumber": 4,
                    "correctTaken": 17561,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Confounding",
                    "choiceNumber": 5,
                    "correctTaken": 133426,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 29,
            "othersAvgTimeSpent": 34,
            "notes": null,
            "peopleTaken": 293842,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 45,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 303,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 19270,
            "questionIndex": 20754,
            "questionText": "<p>A group of genetic epidemiologists conducts a case-control study to explore whether the presence of estrogen receptor (ER) and progesterone receptor (PR) in breast tissue in women with benign breast diseases (BBD) is associated with subsequent development of breast cancer.&nbsp; Women with breast cancer and prior BBDs (860 cases) are matched to women with prior BBD who have been diagnosed as free from breast cancer (1,720 controls).&nbsp; The matching factors are age at BBD diagnosis, type of BBD, and follow&#8208;up time since BBD diagnosis.&nbsp; ER and PR expressions are obtained from the specimens of women with BBD.&nbsp; The study shows an association between higher expressions of ER and PR and subsequent breast cancer in women with BBDs that is statistically significant at the 1% level.&nbsp; Which of the following is the most appropriate interpretation of the study results?</p>",
            "questionHeader": "",
            "explanationText": "<p>This <strong>case-control study</strong> in women with benign breast diseases (BBDs) evaluates the <strong>association</strong> between the higher expression of estrogen receptor (ER) and progesterone receptor (PR) and subsequent breast cancer development.&nbsp; Therefore, the <strong>null hypothesis</strong> (H<font size=\"2\"><sub>0</sub></font>) of the study is:</p><p style=\"margin-left: 3em;\">H<font size=\"2\"><sub>0</sub></font>:&nbsp; <strong>No association</strong> exists between ER/PR expression and subsequent breast cancer in women with BBDs.</p><p>The study results show a statistically significant association at the 1% level.&nbsp; The <strong>significance level &#945;</strong> refers to the probability of rejecting a null hypothesis (H<font size=\"2\"><sub>0</sub></font>) that is true <strong>(ie, Type I error)</strong>; it is a <strong>predefined threshold</strong> (usually set at 1% or 5%) used to determine whether study results are too rare to be consistent with H<font size=\"2\"><sub>0</sub></font>, in which case results are considered statistically significant.&nbsp; The <em>p</em>-value of a hypothesis test is compared to &#945; to <strong>determine statistical significance</strong>.</p><ul><li><p>A <em>p</em>-value &lt; &#945; (eg, <em>p</em> &lt; 0.01) indicates results are inconsistent with H<font size=\"2\"><sub>0</sub></font> (ie, statistically significant association) at that significance level.</p></li><li><p>A <em>p</em>-value &#8805; &#945; (eg, <em>p</em> &#8805; 0.01) indicates results are consistent with H<font size=\"2\"><sub>0</sub></font> (ie, no statistically significant association) at that significance level.</p></li></ul><p>The <strong><em>p</em>-value</strong> (sometimes inaccurately referred to as the probability of obtaining a result by chance alone) is the <strong>probability</strong> of obtaining the <strong>observed results when H<font size=\"2\"><sub>0</sub></font> is assumed to be true</strong> (eg, no association is expected).</p><p>In this study, the association was <strong>statistically significant at the 1% level</strong>.&nbsp; This result means that the study used a significance level &#945; of 0.01 (ie, 1%) to evaluate the association, and that <strong><em>p</em> &lt; 0.01</strong>.&nbsp; Therefore, the most appropriate interpretation of the results is that such association will occur by chance &lt;1% of the time if no association is expected (ie, if H<font size=\"2\"><sub>0</sub></font> is assumed to be true).</p><p>In contrast, the significance level does not offer any information about the magnitude of risk (eg, odds of developing breast cancer) <strong>(Choices A and E)</strong>, causality of the association <strong>(Choice C)</strong>, or risk reduction <strong>(Choice D)</strong>.</p><p><strong>Educational objective:</strong><br>The <em>p</em>-value is the probability of obtaining a result by chance alone when a null hypothesis H<font size=\"2\"><sub>0</sub></font> is assumed to be true.&nbsp; Its magnitude is compared to a predetermined significance level &#945; (usually set at 5% or 1%) to determine statistical significance.&nbsp; A <em>p</em>-value less than the significance level &#945; indicates that results will occur by chance less than &#945;% when H<font size=\"2\"><sub>0</sub></font> is assumed to be true.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24197,
            "topic": "Statistical vs. clinical significance",
            "titleId": 24197,
            "title": "Statistical vs. clinical significance",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "About 1 of 100 of women with BBD who have higher ER/PR expression will develop breast cancer in their lifetime",
                    "choiceNumber": 1,
                    "correctTaken": 479,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "An association between higher ER/PR expression and subsequent breast cancer development in women with BBD will occur by chance less than 1% of the time if no such association is expected",
                    "choiceNumber": 2,
                    "correctTaken": 7860,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "In women with BBD, at least 1% of subsequent breast cancer is due to higher ER/PR expression",
                    "choiceNumber": 3,
                    "correctTaken": 502,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Personalizing the clinical management of women with BBD and higher ER/PR expression may reduce their risk for subsequent breast cancer by 1%",
                    "choiceNumber": 4,
                    "correctTaken": 96,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Women with BBD and higher ER/PR expression have at least a 1% higher risk for subsequent breast cancer than women with BBD and lower ER/PR expression",
                    "choiceNumber": 5,
                    "correctTaken": 1697,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 196,
            "othersAvgTimeSpent": 102,
            "notes": null,
            "peopleTaken": 10634,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1175,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 18945,
            "questionIndex": 20426,
            "questionText": "<p>A prospective, randomized controlled trial compared the rates of serious medical errors made in intensive care units (ICUs) by interns working a traditional schedule and interns working an intervention schedule.&nbsp; The traditional schedule was extended (&#8805;24 hr) work shifts every other shift (an every-third-night call schedule); the intervention schedule eliminated extended work shifts and reduced the number of hours worked per week.&nbsp; Incidents were identified using a multidisciplinary 4-pronged approach that included direct, continuous observation.&nbsp; Two physicians who were unaware of the interns&#39; schedule assignments independently rated each incident.&nbsp; The study involved 2,450 patient-days, 1,200 during the traditional schedule and 1,250 during the intervention schedule.&nbsp; It represented 634 admissions to the ICUs (385 during the traditional schedule and 249 during the intervention schedule) and 5,888 hours of direct observation of interns.&nbsp; An excerpt of the study results is shown below.</p><div id=\"div_T64888\"><table class=\"table-default-style\" style=\"width:576px\"><tbody><tr><td style=\"width:40.6%;\"></td><td style=\"width:20.0%;\"><p align=\"center\"><strong>Traditional schedule</strong></p></td><td style=\"width:20.0%;\"><p align=\"center\"><strong>Intervention schedule</strong></p></td><td style=\"width:19.4%;\"></td></tr><tr><td style=\"width:40.6%;\"><p><strong>Serious medical errors made by interns in the ICU</strong></p></td><td colspan=\"2\" style=\"width:39.98%;\"><p align=\"center\"><strong>Number of errors</strong></p></td><td style=\"width:19.4%;\"><p align=\"center\"><strong><em>p</em>-value</strong></p></td></tr><tr><td style=\"width:40.6%;\"><p>Serious medical errors</p></td><td style=\"width:20.0%;\"><p align=\"center\">176</p></td><td style=\"width:20.0%;\"><p align=\"center\">91</p></td><td style=\"width:19.4%;\"><p align=\"center\">&lt;0.001</p></td></tr><tr><td style=\"width:40.6%;\"><p>Preventable adverse events</p></td><td style=\"width:20.0%;\"><p align=\"center\">27</p></td><td style=\"width:20.0%;\"><p align=\"center\">15</p></td><td style=\"width:19.4%;\"><p align=\"center\">0.23</p></td></tr><tr><td style=\"width:40.6%;\"><p>Intercepted serious errors</p></td><td style=\"width:20.0%;\"><p align=\"center\">91</p></td><td style=\"width:20.0%;\"><p align=\"center\">50</p></td><td style=\"width:19.4%;\"><p align=\"center\">0.01</p></td></tr><tr><td style=\"width:40.6%;\"><p>Nonintercepted serious errors</p></td><td style=\"width:20.0%;\"><p align=\"center\">60</p></td><td style=\"width:20.0%;\"><p align=\"center\">25</p></td><td style=\"width:19.4%;\"><p align=\"center\">&lt;0.001</p></td></tr></tbody></table></div><p>Which of the following is the approximate proportion of decreased risk in nonintercepted serious errors per patient-day among interns in the intervention schedule relative to those in the traditional schedule?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34642\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\" style=\"width:40.0%\"><p align=\"center\"><strong>Common measures of therapeutic efficacy</strong></p></td></tr><tr><td style=\"width:20.0%\"><p align=\"center\"><strong>Term</strong></p></td><td style=\"width:40.0%\"><p align=\"center\"><strong>Definition</strong></p></td><td style=\"width:40.0%\"><p align=\"center\"><strong>Calculation</strong></p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Absolute risk reduction (ARR)</strong></p></td><td style=\"width:40.0%;\"><p>Percentage indicating the actual difference in event rate between control &amp; treatment groups</p></td><td style=\"width:40.0%;\"><p align=\"center\">ARR = control rate &ndash; treatment rate</p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Relative risk reduction (RRR)</strong></p></td><td style=\"width:40.0%;\"><p>Percentage indicating relative reduction in the treatment event rate compared to the control group</p></td><td style=\"width:40.0%;\"><p align=\"center\">RRR = ARR / control rate</p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Relative risk (RR)</strong></p></td><td style=\"width:40.0%;\"><p>Ratio of the probability of an event occurring in the treatment group compared to the control group</p></td><td style=\"width:40.0%;\"><p align=\"center\">RR = treatment rate / control rate</p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Number needed to treat (NNT)</strong></p></td><td style=\"width:40.0%;\"><p>Number of individuals who need to be treated to prevent a negative outcome in 1 patient</p></td><td style=\"width:40.0%;\"><p align=\"center\">NNT = 1 / ARR</p></td></tr></tbody></table></div><p><strong>Relative risk reduction (RRR)</strong> describes the <strong>difference in risk</strong> (or rate) of an unfavorable outcome (eg, nonintercepted serious error) between a treatment group (eg, intervention schedule) and a control group (eg, traditional schedule) <strong>relative to the control group</strong> (ie, the proportion of decreased risk due to the treatment compared to the control group).&nbsp; RRR is calculated as follows:</p><p style=\"text-align:center;\">RRR = (Rate<font size=\"2\"><sub>control</sub></font> &#8722; Rate<font size=\"2\"><sub>treatment</sub></font>) / Rate<font size=\"2\"><sub>control</sub></font></p><p>In this example, Rate<font size=\"2\"><sub>control</sub></font> and Rate<font size=\"2\"><sub>treatment</sub></font> must be calculated first based on the information given:</p><ul><li>The number of nonintercepted serious errors in the traditional schedule (control) group is 60, and the total number of patient-days during the traditional schedule is 1,200, so:</li></ul><p style=\"text-align:center;\"><strong>Rate</strong><font size=\"2\"><sub><strong>control</strong></sub></font>&nbsp;<strong>= 60/1,200 = 0.05 (Choice C)</strong></p><ul><li>The number of nonintercepted serious errors in the intervention schedule (treatment) group is 25, and the total number of patient-days during the intervention schedule is 1,250, so:</li></ul><p style=\"text-align:center;\"><strong>Rate</strong><font size=\"2\"><sub><strong>treatment</strong></sub></font>&nbsp;<strong>= 25/1,250 = 0.02 (Choice A)</strong></p><p>Therefore, RRR for nonintercepted serious errors in the intervention schedule group is calculated as follows:</p><p style=\"text-align:center;\"><strong>RRR</strong> = (0.05 &#8722; 0.02) / 0.05 = <strong>0.60</strong></p><p>Alternately, RRR may be calculated using relative risk (RR):</p><p style=\"text-align:center;\">RRR = 1 &#8722; RR</p><p>For this example, RR is the ratio of the rate of nonintercepted serious errors in the intervention schedule group to the rate of nonintercepted serious errors in the traditional schedule group.&nbsp; It is calculated as follows:</p><p style=\"text-align:center;\">RR = (Rate<font size=\"2\"><sub>treatment</sub></font> / Rate<font size=\"2\"><sub>control</sub></font>) = (0.02 / 0.05) = 0.40</p><p>Therefore:</p><p style=\"text-align:center;\">RRR = 1 &#8722; 0.40 = 0.60</p><p>Note:&nbsp; The formula for RRR based on RR can be derived from the formula for RRR based on the difference in rates: RRR = (Rate<font size=\"2\"><sub>control</sub></font> &#8722; Rate<font size=\"2\"><sub>treatment</sub></font>) / Rate<font size=\"2\"><sub>control</sub></font> = 1 &#8722; (Rate<font size=\"2\"><sub>treatment</sub></font> / Rate<font size=\"2\"><sub>control</sub></font>) = 1 &#8722; RR.</p><p><strong>(Choice B)</strong>&nbsp; Absolute risk reduction (ARR) describes the absolute difference in rate of an unfavorable outcome (eg, nonintercepted serious error) between a treatment group (eg, intervention schedule) and a control group (eg, traditional schedule).&nbsp; It is calculated as: ARR = (Rate<font size=\"2\"><sub>control</sub></font> &#8722; Rate<font size=\"2\"><sub>treatment</sub></font>) = 0.05 &#8722; 0.02 = 0.03.</p><p><strong>Educational objective:</strong><br>Relative risk reduction (RRR) measures how much a treatment reduces the risk (ie, rate) of an unfavorable outcome.&nbsp; RRR may be calculated using absolute risk reduction (ARR) or relative risk (RR) as follows:</p><p style=\"text-align:center;\">RRR = ARR / Rate<font size=\"2\"><sub>control</sub></font> = (Rate<font size=\"2\"><sub>control</sub></font> &#8722; Rate<font size=\"2\"><sub>treatment</sub></font>) / Rate<font size=\"2\"><sub>control</sub></font></p><p style=\"text-align:center;\">RRR = 1 &#8722; RR</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 20684,
            "topic": "Risk",
            "titleId": 20684,
            "title": "Risk",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "0.02",
                    "choiceNumber": 1,
                    "correctTaken": 427,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "0.03",
                    "choiceNumber": 2,
                    "correctTaken": 2279,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "0.05",
                    "choiceNumber": 3,
                    "correctTaken": 1513,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "0.20",
                    "choiceNumber": 4,
                    "correctTaken": 1070,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "0.60",
                    "choiceNumber": 5,
                    "correctTaken": 5165,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 396,
            "othersAvgTimeSpent": 155,
            "notes": null,
            "peopleTaken": 10454,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 49,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 268,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 20042,
            "questionIndex": 21535,
            "questionText": "<p>An otorhinolaryngology resident conducted a cross-sectional study on neurocognitive dysfunction in patients with chronic rhinosinusitis (CRS).&nbsp; The study hypothesis stated that the cognitive dysfunction symptoms reported by patients may be related to severity of rhinologic symptoms, facial pain, or chronic inflammation seen in CRS.&nbsp; A correlation analysis of pain and cognitive dysfunction, disease-specific quality of life, and clinical measures of disease severity were conducted.&nbsp; Initial study results showed that lower levels of cognitive dysfunction tended to relate to lower scores in pain severity and that the relationship was very weak but statistically significant.&nbsp; Based on this information, which of the following statements is most correct about the correlation coefficient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"35793\" src=\"https://www.uworld.com/media/L59668.png\" ></p><p>The <strong>correlation coefficient</strong> <em><strong>r</strong></em> describes the <strong>direction</strong> (negative or positive) and the <strong>strength</strong> (values closer to &#8722;1 or 1 indicate stronger relationships) of the linear relationship between 2 quantitative variables:</p><ul><li><p><strong><em>r</em> &lt; 0</strong> indicates that, as <strong>one variable increases, the other variable decreases</strong>.&nbsp; This means that lower values of one variable tend to relate to higher values of the other variable, and vice versa.</p></li><li><p><strong><em>r</em> &gt; 0</strong> indicates that <strong>both variables increase (or decrease) together</strong>.&nbsp; This means that lower values of one variable tend to relate to lower values of the other variable, and vice versa.</p></li></ul><p>In this study, results reveal that lower levels of cognitive dysfunction tended to relate to lower scores in pain severity.&nbsp; This means that both <strong>variables decrease together</strong>, so the <strong>correlation</strong> coefficient must be <strong>positive (Choices A and B)</strong>.&nbsp; Study results also showed that the relationship was very weak but statistically significant.&nbsp; Because the relationship is described as <strong>very weak</strong>, the correlation coefficient must be <strong>closer to 0 than to 1 (Choice D)</strong>.</p><p><strong>Educational objective:</strong><br>The correlation coefficient <em>r</em> describes the direction (negative or positive) and the strength (values closer to &#8722;1 or 1 indicate stronger relationships) of the linear relationship between 2 quantitative variables.&nbsp; It does not necessarily imply causality.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 10618,
            "topic": "Correlation coefficient",
            "titleId": 10618,
            "title": "Correlation coefficient",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "It is negative and probably closer to &#8722;1 than to 0",
                    "choiceNumber": 1,
                    "correctTaken": 432,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "It is negative and probably closer to 0 than to &#8722;1",
                    "choiceNumber": 2,
                    "correctTaken": 1328,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "It is positive and probably closer to 0 than to 1",
                    "choiceNumber": 3,
                    "correctTaken": 8018,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "It is positive and probably closer to 1 than to 0",
                    "choiceNumber": 4,
                    "correctTaken": 917,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 177,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 10695,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 262,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 20302,
            "questionIndex": 21801,
            "questionText": "<p>A study conducted in the state of Michigan evaluated the safety and effectiveness of reduced-dose apixaban (2.5 mg twice daily) compared to standard-dose apixaban (5 mg twice daily) for prevention of thromboembolism in patients with nonvalvular atrial fibrillation (NVAF).&nbsp; Patients with NVAF who recently started taking apixaban were followed for 24 months.&nbsp; Apixaban doses were selected at the discretion of treating physicians.&nbsp; Primary outcomes were hemorrhagic and thromboembolic events.&nbsp; Study results are summarized below:</p><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse\"><tbody style=\"text-align:center\"><tr><td></td><td colspan=\"2\" style=\"vertical-align:middle;\">Incidence rates</td><td rowspan=\"2\" style=\"vertical-align:middle;\"><em>p-value</em></td></tr><tr><td style=\"vertical-align:middle;\">Outcomes</td><td style=\"vertical-align:middle;\">Reduced-dose group<br>(%/year)</td><td style=\"vertical-align:middle;\">Standard-dose group<br>(%/year)</td></tr><tr><td style=\"vertical-align:middle;\">Major hemorrhage</td><td style=\"vertical-align:middle;\">3.00</td><td style=\"vertical-align:middle;\">1.93</td><td style=\"vertical-align:middle;\">0.001</td></tr><tr><td style=\"vertical-align:middle;\">Thromboembolism</td><td style=\"vertical-align:middle;\">1.40</td><td style=\"vertical-align:middle;\">0.98</td><td style=\"vertical-align:middle;\">0.001</td></tr></tbody></table><p>Researchers concluded that the reduced-dose group showed higher incidence rates of thromboembolic and major hemorrhagic events than the standard-dose group.&nbsp; Which of the following raises the most concern regarding this conclusion?</p>",
            "questionHeader": "",
            "explanationText": "<p>This study evaluated the safety and effectiveness of reduced-dose apixaban (2.5 mg twice daily) compared to standard-dose apixaban (5 mg twice daily) for prevention of thromboembolism in patients with nonvalvular atrial fibrillation (NVAF).&nbsp; Patients with NVAF who recently started taking apixaban were included in the study.&nbsp; Each patient received either the reduced dose or the standard dose <strong>at the discretion of the treating physician</strong> and was followed for 24 months.&nbsp; This discretion in selecting the dose suggests that the treatments (ie, reduced dose, standard dose) were <strong>not randomly assigned</strong> to patients.</p><p>Nonrandom treatment assignment may lead to <strong>selection bias</strong> because patients may have an <strong>unequal chance</strong> of receiving either <strong>treatment</strong>.&nbsp; In this study, some physicians may have preferentially assigned older patients with more health issues to receive reduced-dose apixaban because they were worried about a greater risk of hemorrhage among these patients.&nbsp; This situation often leads to nonequivalent groups, which means that any effect of the treatment (eg, reduced dose) might be a result of the groups&nbsp;being different at the outset (eg, older patients, more health issues) rather than different at the end because of the treatment <strong>(Choice E)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; The study was conducted in a single US state; however, no information is given to identify where the participants came from (eg, single state, multiple states), and no reason exists to assume the study location biased the results.&nbsp; Based on the given data, determining whether there is a threat to the external validity of the study is not possible.</p><p><strong>(Choice B)</strong>&nbsp; The study followed participants for 24 months with incidence rates of approximately 1%-3%/year for the events of interests (ie, major hemorrhage, thromboembolism).&nbsp; This follow-up time is long enough to observe a sufficiently large number of events in patients with NVAF.</p><p><strong>(Choice D)</strong>&nbsp; The study&#39;s objective was to compare the safety and effectiveness of reduced-dose and standard-dose apixaban in preventing thromboembolism in patients with NVAF.&nbsp; Therefore, researchers were interested in comparing these 2 dosages only.&nbsp; The use of placebo as a comparator is unnecessary and may be unethical given the known benefits of anticoagulation in patients with NVAF.</p><p><strong>Educational objective:</strong><br>Nonrandom treatment assignment may lead to selection bias because study participants may have an unequal chance of receiving the treatments of interest.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 19502,
            "topic": "Study designs",
            "titleId": 19502,
            "title": "Study designs",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "The external validity of the study is low due to geographic limitation",
                    "choiceNumber": 1,
                    "correctTaken": 653,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The follow-up period is insufficient to observe enough outcomes",
                    "choiceNumber": 2,
                    "correctTaken": 343,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The patients may have an unequal likelihood of receiving either dose",
                    "choiceNumber": 3,
                    "correctTaken": 7572,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The study compared reduced-dose and standard-dose apixaban without a placebo",
                    "choiceNumber": 4,
                    "correctTaken": 966,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There are no significant concerns about the conclusion of the study",
                    "choiceNumber": 5,
                    "correctTaken": 1110,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 141,
            "othersAvgTimeSpent": 89,
            "notes": null,
            "peopleTaken": 10644,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 546,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": [
        {
            "id": 3,
            "title": "",
            "header": null,
            "text": "<p><strong>Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction</strong></p>\r\n<p><strong>Hypothesis:</strong></p>\r\n<p>Is coronary-artery bypass grafting (CABG) superior to optimal medical therapy alone in the treatment of patients with coronary artery disease and heart failure?</p>\r\n<p><strong>Methods:</strong></p>\r\n<p>Design: Randomized clinical trial</p>\r\n<p>Blinding: none</p>\r\n<p>Median follow-up: 56 months</p>\r\n<p>Setting: Multicenter (99 medical centers in 22 countries)</p>\r\n<p>Patients: Patients with a left ventricular ejection fraction of 35% or less and coronary artery disease amenable to CABG.&nbsp; Patients with a stenotic lesion leading to loss of 50% or more of the diameter of the left main coronary artery and/or Canadian Cardiovascular Society class III or IV angina while receiving medical therapy were excluded from the study.&nbsp; (The Canadian Cardiovascular Society angina classification ranges from class 0, which indicates no symptoms, to class IV, which indicates angina at any level of physical exertion.)</p>\r\n<p>Intervention: CABG plus optimal medical therapy vs optimal medical therapy alone</p>\r\n<p>Outcome measures: The primary outcome was the rate of death from any cause.&nbsp; Major secondary outcomes included the rates of death from cardiovascular causes and of death from any cause or hospitalization for cardiovascular causes.</p>\r\n<p><strong>Results: </strong></p>\r\n<p>A total of 1212 patients were randomly assigned to medical therapy alone (602 patients) or medical therapy plus CABG (610 patients).&nbsp; By the end of the follow-up period, 100 patients in the medical-therapy group (17%) underwent CABG, and 555 patients in the CABG group (91%) underwent CABG.</p>\r\n<p>Primary outcome (CABG vs medical therapy alone)<br>\r\nRate of death from any cause Hazards Ratio (HR) 0.86 (0.72-1.04) P= 0.12</p>\r\n<p>Secondary outcomes (CABG vs medical therapy alone)<br>\r\nDeath from any cause within 30 days after randomization HR 3.12 (1.33-7.31) P=0.006<br>\r\nDeath from cardiovascular causes HR 0.81 (0.66-1.00) P=0.05<br>\r\nDeath from any cause or hospitalization for heart failure HR 0.84 (0.71-0.98) P=0.03<br>\r\nDeath from any cause or hospitalization for cardiovascular causes HR 0.74 (0.64-0.85) P&lt;0.001<br>\r\nDeath from any cause or hospitalization for any cause HR 0.81 (0.71-0.93) P=0.003<br>\r\nDeath from any cause or revascularization HR 0.60 (0.51-0.71) P&lt;0.001</p>\r\n<p><strong>Conclusion: </strong></p>\r\n<p>In this randomized trial, there was no significant difference between medical therapy alone and medical therapy plus CABG with respect to the primary end point of death from any cause.</p>\r\n<p><em>Funding Source</em>: Supported by grants from the National Heart, Lung, and Blood Institute and by Abbott Laboratories.</p>\r\n<p><em>Structured abstract is based on</em>: NEJM 2011;364(17):1607-16.<br>\r\n</p>\r\n",
            "difficultyLevelId": 0,
            "poolTypeId": 1,
            "categoryTypeId": 0,
            "abstractAdoptedFrom": "",
            "source": null,
            "sourceLink": null,
            "vocabularyList": null,
            "qbankId": 2,
            "footnotesList": null,
            "abstractCitation": null,
            "passagePreviewList": null,
            "annotations": null
        }
    ],
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}